Why Are Patients Readmitted After Surgery for Gastric Cancer? Predictors of 30‐Day Readmission Following Gastrectomy: A Single‐Center Retrospective Cohort Study
ANZ Journal of Surgery · 2026
DOI: 10.1111/ans.70302 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift ANZ Journal of Surgery, 2026. Verfasst von Tamir Lotan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Upper GI Surgery, Department of General Surgery, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Patient Readmission, Gastrectomy, Stomach Neoplasms, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
Gastric cancer (GC) remains a major global health concern, with gastrectomy serving as the primary curative intervention. Early hospital readmission after gastrectomy is an important quality‐of‐care metric; however, data on its predictors and clinical implications remain limited. This study aimed to evaluate the incidence, timing, causes, and predictors of early readmission (within 30 days) after gastrectomy for GC.
Methods
We conducted a retrospective single‐center cohort study of patients who underwent gastrectomy for GC between January 2012 and January 2023. Patients with non‐adenocarcinoma histology or cytoreductive/bariatric indications were excluded. The primary outcome was 30‐day readmission, defined as inpatient hospitalization within 30 days of discharge. Univariable and multivariable logistic regression models were used to identify predictors of readmission.
Results
Of 416 patients included, 103 (24.8%) presented to the emergency department (ED) within 30 days of discharge, and 72 (17.3%) were readmitted. The most common causes of readmission were intra‐abdominal infections (26.4%), gastrointestinal symptoms (20.8%), and bleeding (12.5%). Readmitted patients had a significantly higher Charlson comorbidity index (median: 6 vs. 5, p = 0.002), more postoperative complications (54.2% vs. 38.7%, p = 0.018), and higher 90‐day mortality (8.3% vs. 1.2%, p = 0.003). In multivariable analysis, a higher comorbidity burden and postoperative complications showed trends toward association with readmission but did not reach statistical significance.
Conclusions
Thirty‐day readmission after gastrectomy was associated with comorbidity burden and postoperative complications. Although these factors did not remain statistically significant in adjusted analyses, they may inform targeted discharge planning and early follow‐up. Improved perioperative care and risk‐based post‐discharge interventions may reduce readmissions and improve outcomes in high‐risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Upper GI Surgery, Department of General Surgery, Sheba Medical Center, Ramat Gan, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University.
- Arrow Program for Medical Research Education, Sheba Medical Center, Ramat-Gan, Israel.
ORCID-Profile: Tamir Lotan, Yehonatan Nevo
Zitieren
APA
Lotan, T., Braun, J., Jacoby, H., Nevo, Y., & Goldes, Y. (2026). Why Are Patients Readmitted After Surgery for Gastric Cancer? Predictors of 30‐Day Readmission Following Gastrectomy: A Single‐Center Retrospective Cohort Study. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70302
Vancouver
Lotan T, Braun J, Jacoby H, Nevo Y, Goldes Y. Why Are Patients Readmitted After Surgery for Gastric Cancer? Predictors of 30‐Day Readmission Following Gastrectomy: A Single‐Center Retrospective Cohort Study. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70302
BibTeX
@article{Lotan2026,
author = {Lotan, Tamir and Braun, Jossy and Jacoby, Harel and Nevo, Yehonatan and Goldes, Yuri},
title = {Why Are Patients Readmitted After Surgery for Gastric Cancer? Predictors of 30‐Day Readmission Following Gastrectomy: A Single‐Center Retrospective Cohort Study},
journal = {ANZ Journal of Surgery},
year = {2026},
doi = {10.1111/ans.70302}
}
EUVIMED